Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 07 Nov 2024

Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients

in Cancer Immunity and Immunotherapy

Evan W. Davis
Hua-Hsin Hsiao
Nancy Barone
Spencer Rosario
Rikki Cannioto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419257

1,605 views

Original Research

Published on 07 Nov 2024

Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts

in Cancer Immunity and Immunotherapy

Marco Erreni
Maria Rita Fumagalli
Raffaella D’Anna
Mauro Sollai
Silvia Bozzarelli
Gennaro Nappo
Damiano Zanini
Raffaella Parente
Cecilia Garlanda
Lorenza Rimassa

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472433

2,756 views

Correction

Published on 07 Nov 2024

Corrigendum: Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites

in Cancer Immunity and Immunotherapy

Xin Zhuang
Qingning Yin
Rong Yang
Xiaoying Man
Ruochen Wang
Hui Geng
Yifen Shi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498574

761 views

Original Research

Published on 07 Nov 2024

Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy

in Cancer Immunity and Immunotherapy

Giovanna Fiore
Wolfgang Weckwarth
Kerstin Paetzold
Llucia Albertí Servera
Manuela Gies
Jakob Rosenhauer
Martina Antoniolli
Sina Nassiri
Stephan Schmeing
Steffen Dettling

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433119

1,797 views

Original Research

Published on 07 Nov 2024

Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer

in Cancer Immunity and Immunotherapy

Yue Pan
Lei Fei
Shihua Wang
Hua Chen
Changqing Jiang
Hong Li
Changsong Wang
Yao Yang
Qinggao Zhang
Yongwen Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487966

3,159 views

Systematic Review

Published on 07 Nov 2024

Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Yonghua Zhu
Jingyao She
Rong Sun
XinXin Yan
Xinyao Huang
Peijuan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493773

1,542 views

Review

Published on 07 Nov 2024

Research progress of CD80 in the development of immunotherapy drugs

in Cancer Immunity and Immunotherapy

Lanying Li
Lei Yang
DePeng Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1496992

1,275 views
1 citation

General Commentary

Published on 07 Nov 2024

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study

in Cancer Immunity and Immunotherapy

Mehmet Fatih Ozbay

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476215

465 views

Original Research

Published on 07 Nov 2024

Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Qian Xu
Dan Yi
Caiyan Jia

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463017

1,436 views

Original Research

Published on 06 Nov 2024

Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study

in Cancer Immunity and Immunotherapy

Jiaqing Liu
Dongchen Sun
Shuoyu Xu
Jiayi Shen
Wenjuan Ma
Huaqiang Zhou
Yuxiang Ma
Yaxiong Zhang
Wenfeng Fang
Yuanyuan Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485703

1,514 views

Original Research

Published on 06 Nov 2024

A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma

in Cancer Immunity and Immunotherapy

Yizhuo Wang
Xin Wang
Yang Liu
Jiayuan Xu
Jiyuan Zhu
Yufu Zheng
Quan Qi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467052

2,043 views

Case Report

Published on 06 Nov 2024

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

in Cancer Immunity and Immunotherapy

Chenghao Fu
Haonan Du
Qiang Wang
Weiyou Zhu
Guangli Bian
Zhujuan Zhong
Yuheng Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452195

1,094 views
1 citation

Review

Published on 06 Nov 2024

Tertiary lymphoid structures in ovarian cancer

in Cancer Immunity and Immunotherapy

Guojuan Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465516

1,776 views

Mini Review

Published on 06 Nov 2024

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

in Cancer Immunity and Immunotherapy

Yexin Zhou
Shanshan Wei
Menghui Xu
Xinhui Wu
Wenbo Dou
Huakang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489649

3,447 views
1 citation

Mini Review

Published on 06 Nov 2024

Neoantigen prioritization based on antigen processing and presentation

in Cancer Immunity and Immunotherapy

Serina Tokita
Takayuki Kanaseki
Toshihiko Torigoe

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487378

1,296 views

Editorial

Published on 05 Nov 2024

Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells

in Cancer Immunity and Immunotherapy

Rosanna Paciucci
Amancio Carnero
Matilde Esther LLeonart

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505225

613 views

Navigation group

Articles

Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients

Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts

Corrigendum: Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites

Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy

Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer

Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Research progress of CD80 in the development of immunotherapy drugs

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study

Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study

Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study

A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Tertiary lymphoid structures in ovarian cancer

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges

Neoantigen prioritization based on antigen processing and presentation

Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells